Skip to main content
Erschienen in: BMC Medicine 1/2015

Open Access 01.12.2015 | Research article

Consumption of whole grains and cereal fiber and total and cause-specific mortality: prospective analysis of 367,442 individuals

verfasst von: Tao Huang, Min Xu, Albert Lee, Susan Cho, Lu Qi

Erschienen in: BMC Medicine | Ausgabe 1/2015

Abstract

Background

Intakes of whole grains and cereal fiber have been inversely associated with the risk of chronic diseases; however, their relation with total and disease-specific mortality remain unclear. We aimed to prospectively assess the association of whole grains and cereal fiber intake with all causes and cause-specific mortality.

Methods

The study included 367,442 participants from the prospective NIH-AARP Diet and Health Study (enrolled in 1995 and followed through 2009). Participants with cancer, heart disease, stroke, diabetes, and self-reported end-stage renal disease at baseline were excluded.

Results

Over an average of 14 years of follow-up, a total of 46,067 deaths were documented. Consumption of whole grains were inversely associated with risk of all-cause mortality and death from cancer, cardiovascular disease (CVD), diabetes, respiratory disease, infections, and other causes. In multivariable models, as compared with individuals with the lowest intakes, those in the highest intake of whole grains had a 17% (95% CI, 14–19%) lower risk of all-cause mortality and 11–48% lower risk of disease-specific mortality (all P for trend <0.023); those in the highest intake of cereal fiber had a 19% (95% CI, 16–21%) lower risk of all-cause mortality and 15–34% lower risk of disease-specific mortality (all P for trend <0.005). When cereal fiber was further adjusted, the associations of whole grains with death from CVD, respiratory disease and infections became not significant; the associations with all-cause mortality and death from cancer and diabetes were attenuated but remained significant (P for trend <0.029).

Conclusions

Consumption of whole grains and cereal fiber was inversely associated with reduced total and cause-specific mortality. Our data suggest cereal fiber is one potentially protective component.
Hinweise
An erratum to this article can be found at http://​dx.​doi.​org/​10.​1186/​s12916-015-0338-z.
An erratum to this article is available at http://​dx.​doi.​org/​10.​1186/​s12916-015-0338-z.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

TH and LQ conceived the study. TH, MX, and LQ analyzed the data and wrote the draft of the paper. MX, AL, SC, and LQ contributed to writing, reviewing, and revising of the paper. LQ is the guarantor. All authors read and approved the final manuscript.
Abkürzungen
CI
Confidence intervals
CVD
Cardiovascular diseases
FFQ
Food frequency questionnaire
HR
Hazard ratio
NIH
National Institutes of Health

Background

Grains, also called cereals, are the seeds of plants cultivated for food. When whole, they include the germ, bran, and endosperm [1]. Most whole grains are abundant sources of dietary fiber and other nutrients, such as minerals and antioxidants, which have shown beneficial effects on human health including improvement of weight loss, insulin sensitivity, and lipid profile, as well as inhibition of systemic inflammation [2-4].
In epidemiology studies, evidence is accumulating indicating that consumption of whole grain products or their effective components, especially dietary fiber found in the grain, i.e., cereal fiber, may reduce the risk of chronic disease. Several recent meta-analyses taking into account a large number of subjects and prospective studies showed significant and consistent protective effects of high intake of whole grains and cereal fiber on type 2 diabetes [5], cardiovascular disease (CVD) [6], and certain cancers (e.g., colorectal cancer) [7]. In our earlier analysis in the Nurses’ Health Study, we observed potential protective effects of whole grains on total or cardiovascular mortality in diabetic women [8]. Although the National Institutes of Health (NIH)-AARP Diet and Health Study previously reported that dietary fiber intake was inversely associated with the risk of total death and death from CVD, infectious diseases, and respiratory diseases [9], few studies have prospectively examined the associations of whole grains and its components, such as cereal fiber, with total or disease-specific mortality.
In the present study, we used data from 367,442 people who were at risk for a total of 12.3 million person-years. We aimed to provide reliable estimates of independent associations between baseline whole grains and cereal fiber intake and the risk of total or cause-specific death from CVD, cancers, diabetes, and other diseases.

Methods

Study population

The NIH-AARP Diet and Health Study included 566,399 AARP members aged 50 to 71 from six US states (California, Florida, Louisiana, New Jersey, North Carolina, and Pennsylvania) and two metropolitan areas (Atlanta, Georgia, and Detroit, Michigan) [10]. Participants responded to a questionnaire mailed in October 1995 and December 1997. Details of the NIH-AARP Study have been previously described [11]. Among participants who returned the questionnaires with satisfactory dietary data, we excluded individuals who indicated that they were proxies for the intended respondent (n = 15,760) as well as those who had cancer (n = 50,591), heart disease (n = 80,254), stroke (n = 12,812), diabetes (n = 52,647), or self-reported end-stage renal disease at baseline (n = 1,299). We also excluded those who reported extreme consumption (>2 times the interquartile ranges of Box-Cox transformed intake) of total energy (n = 3,771) and dietary fiber (n = 3,324). Exclusion of individuals reporting extreme energy intake is widely used in nutritional epidemiology studies since these participants are more likely to over- or under-report their intake [12]. After exclusions (n = 198,957), the analytic cohort included 367,442 individuals. The NIH-AARP Diet and Health study was approved by the Special Studies Institutional Review Board of the US National Cancer Institute. All participants provided written informed consent.

Assessment of dietary exposures

At baseline, dietary intake was assessed with a self-administered 124-item food frequency questionnaire (FFQ), which was an early version of the Diet History Questionnaire developed at the National Cancer Institute [13,14]. Participants were asked to report their usual frequency of intake and portion size over the past 12 months using 10 predefined frequency categories ranging from never to 6+ times per day for beverages and from never to 2+ times per day for solid foods with three portion size categories. The food items, portion sizes, and nutrient database were constructed using the US Department of Agriculture’s 1994–1996 Continuing Survey of Food Intakes by Individuals. The FFQ used in the study was calibrated using two non-consecutive 24-hour dietary recalls in 1953 NIH-AARP study participants. The nutrient database for dietary fiber was based on AOAC methods.
The whole grains were defined as the whole grain part of each product. The US Department of Agriculutre’s Pyramid Servings Database enabled us to accurately estimate whole-grain intake from all foods in the FFQ. The sources of whole-grain intake in the FFQ used in our study were ready-to-eat cereals, high-fiber cereals, other fiber cereals, whole-grain breads or dinner rolls, cooked cereal, popcorn, pancakes, waffles, French toast or crepes, rice or other cooked grains, bagels, English muffins, tortillas, pasta, crackers, chips, cookies or brownies, sweet pastries, and pies. In this Continuing Survey of Food Intakes by Individuals dataset., whole grain foods were defined as those containing at least 25% whole grains and/or bran. Main fibers are from fruit, grains, vegetables, and beans in the present study. Cereal fiber was defined as fiber from all cereals (e.g., ready-to-eat cereals, high-fiber cereals, cooked cereal, and other fiber cereals) and grain-based products.
In specifying numbers of deaths by intake quintile, the number of deaths is determined by the energy-adjusted intake quintile for the entire population; when deaths are specific to a sex, we used the quintiles within the sex. We also collected demographic, anthropometric, and lifestyle information, including history of smoking (the number of cigarettes smoked per day), time of smoking cessation (<1 years, 1 to 5 years, 5 to 10 years, or ≥10 years before baseline), physical activity (never, rare, 1 to 2, 3 to 4, ≥5 hours/week), alcohol intake (g/day) family history of cancers, menopausal hormone therapy use in women, and some medical conditions at baseline.

Ascertaining mortality

The AARP dataset denotes date of death and cause of death. There are 22 broad categories for cause of death. The modeling analysis for specific cause of death is performed with the study end date of 2008. For total mortality, models for study end dates in 2008 and 2009 were designed. Subjects with date of death after the study’s end date are treated as alive at the end of the study, with no death or cause of death in the model. When the study end date was 2008, and there was a date of death but no cause of death for 2008 or earlier, the subject was not included in the modeling for cause of death, but only total mortality. Thus, when specifying numbers of deaths it depends on both the study end date and whether the cause of death field is missing. Vital status was determined through a periodic linkage of the cohort to the Social Security Administration Death Master File and follow-up searches of the National Death Index Plus for participants who matched the Social Security Administration Death Master File, cancer registry linkage, questionnaire responses, and responses to other mailings. The International Classification of Diseases, Ninth Revision [15] and the International Statistical Classification of Diseases, 10th Revision [16] were used to define death as follows: cancer (ICD-9, 140–239; ICD-10, C00–C97 and D00–D48), CVD (ICD-9, 390–398, 401–404, 410–429, and 440–448; ICD-10, I00–I13, I20–I51, and I70–I78), diabetes (ICD-9, 250; ICD-10, E10–E14), respiratory disease (ICD-9, 480–487 and 490–496; ICD-10, J10–J18 and J40–J47), infections (ICD-9, 001–139; ICD-10, A00–B99), and all other/unknown causes.

Statistical analysis

We used the Cox proportional hazards model to estimate hazard ratios (HRs) and two-sided 95% confidence intervals (CIs) using the SAS PROC PHREG procedure (Version 9.1; SAS Institute Inc., Cary, NC, USA). Person-years of follow-up were calculated from the date of the baseline questionnaire until the date of death or the end of follow-up (December 31, 2009), whichever occurred first. Intake of whole grains and cereal fiber were adjusted for total energy intake using the residual method [17], and were categorized into quintiles.
We presented the results from four analysis models. Model 1, adjusted for age and gender; Model 2, adjusted for age, gender, the number of cigarettes smoked per day, and time of smoking cessation (<1 years, 1 to 5 years, 5 to 10 years, or ≥10 years before baseline); Model 3, adjusted for age, gender, the number of cigarettes smoked per day, time of smoking cessation (<1 years, 1 to 5 years, 5 to 10 years, or ≥10 years before baseline), race or ethnicity group, alcohol intake, education level, marital status (yes, no), health status (poor, fair, good, very good), obesity (underweight, overweight, obesity), physical activity, consumption of red meat (processed and fresh meat), total fruit and total vegetables, total energy intake, and hormone usage; and Model 4, based on Model 3 further adjusted for cereal fiber (whole grains analysis).
For missing data in each covariate, we created indicator variables. Overall, missing data was less than 5%. The model results summary includes the results of statistical tests for trend in the response for the risk variable. Quintiles Trend P denotes the P value when the median value within the risk variable quintile is included in the hazard model as linear.

Results

Table 1 shows baseline characteristics of study participants (n = 367,442), according to intake of whole grains and cereal fiber. During an average of 14 years of follow-up (total person-years, 5,148,760), we documented 46,067 deaths, among them 11,283 from CVD, 19,043 from cancer, 371 from diabetes, 3,796 from respiratory disease, 922 from infection, and 5,223 from other causes. At baseline, intakes of whole grains and cereal fiber were inversely correlated with prevalence of overweight, obesity, and current smoking, as well as intake of red meat. The levels of moderate and vigorous physical activity were higher among participants with higher intakes of whole grains or cereal fiber than those with lower intakes.
Table 1
Baseline characteristics of the study participants according to intake of whole grains and cereal fiber
 
Total participants
Whole grains
Cereal fiber
Q1
Q3
Q5
Q1
Q3
Q5
n
367,442
73,488
73,489
73,489
73,488
73,489
73,489
Age, mean years
61.7
61.1
61.7
62.1
61.0
61.7
62.2
Female, %
43.9
30.7
51.9
40.4
35.0
49.9
40.2
Whites, %
92.9
92.6
92.9
93.2
91.2
93.0
94.4
College graduate, %
41.0
35.2
41.4
44.9
36.2
40.4
46.4
Married, %
68.1
72.7
65.2
68.9
69.8
66.1
69.9
Moderate physical activity (3–4 times/week), %
27.3
23.0
27.8
30.6
23.6
27.2
30.9
Vigorous physical activity (≥5 times/week), %
19.2
17.5
18.0
23.6
18.1
17.6
24.1
Overweight, %
42.4
44.5
42.0
41.0
43.9
42.2
41.1
Obesity, %
19.6
22.7
19.7
16.6
23.6
20.0
15.0
Very good or excellent self-report health, %
61.4
56.5
62.2
64.3
58.8
61.4
65.0
Previous or current use of postmenopausal hormone therapy, %
55.0
47.9
55.6
58.1
45.5
54.4
59.2
Former smoker, %
48.7
48.5
48.2
49.5
47.6
48.4
50.2
Current smoker, %
12.8
21.4
11.3
8.0
21.4
11.5
7.0
Median total energy intake (kcal/d)
1,805
2,394
1,527
1,855
2,330
1,563
1,832
Median alcohol intake (g/d)
14.7
32.5
10.0
8.8
27.5
11.6
9.9
Median servings of food
       
Red meat (oz/d)
2.0
3.1
1.6
1.7
3.1
1.71
1.6
Fruits (cup eq/d)
2.0
2.1
1.8
2.2
2.3
1.8
2.2
Vegetables (cup eq/d)
1.9
2.2
1.7
2.0
2.3
1.7
2.0

Whole grains and cereal fiber intake with total mortality

In age- and gender-adjusted analysis (Model 1), we found that intake of whole grains were inversely associated with all-cause mortality (Table 2). As compared with the lowest quintile, the HRs across increasing quintiles of whole grain intake were 0.78 (95% CI, 0.76–0.80), 0.70 (95% CI, 0.68–0.72), 0.63 (95% CI, 0.61–0.65), and 0.61 (95% CI, 0.59–0.62) (P trend <0.0001). Further adjustment for smoking status and time since smoking cessation (Model 2) did not appreciably change the associations. When the models further included race/ethnicity, education, marital status, self-rated health status, obesity (underweight, overweight, and obesity), physical activity, use of menopausal hormone therapy, and intake of alcohol, red meat, fruits, vegetables, and total energy (Model 3), the highest quintile of whole grain intake was associated with 17% (95% CI, 14–19%) lower risk of all-cause mortality (P trend <0.0001). The associations between whole grain intake and all-cause mortality was attenuated, the highest quintile of whole grain intake was associated with 6% (95% CI, 3–10%) lower risk, but remained significant when cereal fiber was additionally adjusted (Model 4; P trend = 0.002). These results suggested that the protective effects of whole grain may be due, at least in the main part, to its cereal fiber component.
Table 2
Association of whole grain intake with total and cause-specific mortality
 
All participants
Whole grains (oz eq/d)
P trend
Q1 (n = 41,248)
Q2 (n = 41,248)
Q3 (n = 41,249)
Q4 (n = 41,248)
Q5 (n = 41,249)
0.13
0.30
0.47
0.69
1.20
Causes of death
       
All cause
       
No. of deaths
46,067
11,845
9,450
8,694
8,054
8,024
 
Model 1
 
1.00
0.78 (0.76–0.80)
0.70 (0.68–0.72)
0.63(0.61–0.65)
0.61 (0.59–0.62)
<0.0001
Model 2
 
1.00
0.88 (0.86–0.91)
0.83 (0.81–0.85)
0.78 (0.75–0.80)
0.77 (0.75–0.79)
<0.0001
Model 3
 
1.00
0.93 (0.90–0.95)
0.89 (0.87–0.92)
0.85 (0.82–0.87)
0.83 (0.81–0.86)
<0.0001
Model 4
 
1.00
0.96 (0.93–0.99)
0.95 (0.92–0.98)
0.92 (0.89–0.96)
0.94 (0.90–0.97)
0.002
Cardiovascular disease
       
No. of deaths
11,283
2,921
2,330
2,121
1,914
1,997
<0.0001
Model 1
 
1.00
0.78 (0.74–0.83)
0.69 (0.65–0.73)
0.60 (0.57–0.64)
0.60 (0.57–0.64)
<0.0001
Model 2
 
1.00
0.88 (0.83–0.93)
0.81 (0.77–0.86)
0.73 (0.69–0.77)
0.75 (0.71–0.80)
<0.0001
Model 3
 
1.00
0.93 (0.88–0.98)
0.88 (0.83–0.93)
0.81 (0.77–0.86)
0.83 (0.78–0.88)
<0.0001
Model 4
 
1.00
0.96 (0.91–1.02)
0.95 (0.89–1.01)
0.90 (0.84–0.97)
0.95 (0.88–1.03)
0.188
Cancer
       
No. of deaths
19,043
4,836
3,912
3,616
3,388
3,291
 
Model 1
 
1.00
0.79 (0.76–0.83)
0.71 (0.68–0.75)
0.65 (0.62–0.68)
0.61 (0.59–0.64)
<0.0001
Model 2
 
1.00
0.91 (0.87–0.95)
0.86 (0.83–0.90)
0.82 (0.79–0.86)
0.80 (0.76–0.84)
<0.0001
Model 3
 
1.00
0.94 (0.90–0.98)
0.91 (0.87–0.95)
0.88 (0.84–0.92)
0.85 (0.81–0.89)
<0.0001
Model 4
 
1.00
0.96 (0.92–1.00)
0.95 (0.90–0.99)
0.93 (0.88–0.98)
0.93 (0.88–0.99)
0.025
Diabetes
       
No. of deaths
371
113
72
73
66
47
 
Model 1
 
1.00
0.62 (0.46–0.84)
0.62 (0.46–0.83)
0.54 (0.40–0.73)
0.37 (0.27–0.52)
<0.0001
Model 2
 
1.00
0.67 (0.49–0.90)
0.67 (0.50–0.91)
0.60 (0.44–0.82)
0.42 (0.30–0.60)
<0.0001
Model 3
 
1.00
0.71 (0.53–0.96)
0.76 (0.56–1.03)
0.72 (0.53–0.99)
0.52 (0.37–0.75)
0.0009
Model 4
 
1.00
0.74 (0.54–1.00)
0.81 (0.59–1.13)
0.78 (0.55–1.13)
0.57 (0.37–0.89)
0.029
Respiratory disease
  
No. of deaths
3,796
1,123
802
673
606
592
 
Model 1
 
1.00
0.69 (0.63–0.75)
0.56 (0.50–0.61)
0.48 (0.43–0.53)
0.45 (0.41–0.50)
<0.0001
Model 2
 
1.00
0.88 (0.80–0.96)
0.79 (0.72–0.87)
0.74 (0.67–0.82)
0.74 (0.67–0.82)
<0.0001
Model 3
 
1.00
0.99 (0.90–1.09)
0.94 (0.85–1.03)
0.91 (0.82–1.01)
0.89 (0.80–0.98)
0.0099
Model 4
 
1.00
1.02 (0.93–1.12)
1.00 (0.90–1.11)
1.01 (0.90–1.14)
1.03 (0.91–1.18)
0.67
Infections
       
No. of deaths
922
251
184
163
161
163
 
Model 1
 
1.00
0.71 (0.59–0.86)
0.61 (0.50–0.75)
0.58 (0.48–0.71)
0.57 (0.47–0.70)
<0.0001
Model 2
 
1.00
0.78 (0.64–0.94)
0.69 (0.57–0.84)
0.68 (0.55–0.83)
0.68 (0.55–0.83)
0.0002
Model 3
 
1.00
0.84 (0.70–1.02)
0.78 (0.64–0.96)
0.79 (0.65–0.97)
0.77 (0.62–0.95)
0.02
Model 4
 
1.00
0.87 (0.71–1.06)
0.83 (0.67–1.04)
0.87 (0.69–1.10)
0.89 (0.68–1.16)
0.54
Other/unknown causes
No. of deaths
5,223
1,206
1,058
1,038
940
981
 
Model 1
 
1.00
0.86 (0.79–0.93)
0.82 (0.76–0.90)
0.71 (0.66–0.78)
0.72 (0.66–0.78)
<0.0001
Model 2
 
1.00
0.91 (0.84–0.99)
0.90 (0.83–0.98)
0.80 (0.73–0.87)
0.81 (0.74–0.88)
<0.0001
Model 3
 
1.00
0.97 (0.88–1.06)
0.97 (0.89–1.06)
0.87 (0.79–0.96)
0.86 (0.78–0.94)
0.0001
Model 4
 
1.00
0.99 (0.91–1.09)
1.03 (0.93–1.13)
0.96 (0.86–1.06)
0.98 (0.87–1.09)
0.54
Data are hazard ratios (HR) and 95% confidence interval (CI). The numbers of deaths are for participants who died during follow-up. The co-variables are baseline assessments.
Model 1, Adjusted for age and gender; Model 2, Adjusted for age, gender, the number of cigarettes smoked per day, and time of smoking cessation (<1 years, 1 to 5 years, 5 to 10 years, or ≥10 years before baseline); Model 3, Adjusted for age, gender, the number of cigarettes smoked per day, time of smoking cessation (<1 years, 1 to 5 years, 5 to 10 years, or ≥10 years before baseline), race or ethnicity group, alcohol intake, education level, marital status (yes, no), health status (poor, fair, good, very good), obesity (underweight, overweight, obesity), physical activity, consumption of red meat, total fruit and total vegetables, total energy intake, and hormone usage. Model 4, Based on Model 3 further adjusted for cereal fiber.
Similarly, we found that cereal fiber intake was significantly associated with all-cause mortality in age- and gender-adjusted and multivariate-adjusted models (Models 1, 2 and 3; all P trend <0.0001; Table 3). In model 3, the highest quintile of cereal intake was associated with 19% (16–21%) lower risk of all-cause mortality (P trend <0.0001).
Table 3
Association of cereal fiber intake with total and cause-specific mortality
 
All participants
 
Cereal fiber (g/d)
P trend
Q1 (n = 73,488)
Q2 (n = 73,488)
Q3 (n = 73,489)
Q4 (n = 73,488)
Q5 (n = 73,489)
2.02
4.15
5.27
6.65
10.22
Causes of death
All cause
   
No. of deaths
46,067
11,700
9,652
8,664
8,133
7,918
 
Model 1
 
1.00
0.80 (0.78–0.83)
0.70 (0.68–0.72)
0.64 (0.62–0.66)
0.59 (0.58–0.61)
<0.0001
Model 2
 
1.00
0.89 (0.87–0.92)
0.83 (0.81–0.85)
0.78 (0.76–0.81)
0.76 (0.73–0.78)
<0.0001
Model 3
 
1.00
0.93 (0.90–0.95)
0.87 (0.85–0.90)
0.84 (0.81–0.86)
0.81 (0.79–0.84)
<0.0001
Cardiovascular disease
11,283
  
No. of deaths
 
2,901
2,368
2,094
1,986
1,934
 
Model 1
 
1.00
0.80 (0.76–0.85)
0.69 (0.65–0.73)
0.63 (0.59–0.66)
0.57 (0.54–0.61)
<0.0001
Model 2
 
1.00
0.88 (0.83–0.93)
0.80 (0.76–0.85)
0.76 (0.71–0.80)
0.72 (0.68–0.76)
<0.0001
Model 3
 
1.00
0.93 (0.87–0.98)
0.86 (0.81–0.91)
0.83 (0.78–0.88)
0.80 (0.75–0.85)
<0.0001
Cancer
       
No. of deaths
19,043
4,772
3,974
3,616
3,391
3,290
 
Model 1
 
1.00
0.81 (0.78–0.85)
0.72 (0.69–0.76)
0.66 (0.63–0.69)
0.61 (0.59–0.64)
<0.0001
Model 2
 
1.00
0.91 (0.87–0.95)
0.87 (0.83–0.91)
0.83 (0.79–0.86)
0.80 (0.77–0.84)
<0.0001
Model 3
 
1.00
0.94 (0.90–0.98)
0.90 (0.86–0.95)
0.87 (0.83–0.91)
0.85 (0.81–0.89)
<0.0001
Diabetes
   
No. of deaths
371
92
92
72
57
51
 
Model 1
 
1.00
0.92 (0.69–1.22)
0.70 (0.52–0.95)
0.54 (0.39–0.74)
0.45 (0.32–0.64)
<0.0001
Model 2
 
1.00
0.97 (0.73–1.29)
0.77 (0.56–1.04)
0.60 (0.43–0.83)
0.52 (0.37–0.73)
<0.0001
Model 3
 
1.00
1.00 (0.74–1.35)
0.83 (0.60–1.15)
0.70 (0.50–0.99)
0.66 (0.46–0.94)
0.005
Respiratory disease
No. of deaths
3,796
1,082
866
652
649
547
 
Model 1
 
1.00
0.75 (0.68–0.82)
0.54 (0.49–0.59)
0.52 (0.47–0.57)
0.42 (0.38–0.46)
<0.0001
Model 2
 
1.00
0.91(0.83–1.00)
0.76 (0.69–0.84)
0.80 (0.72–0.88)
0.70 (0.63–0.78)
<0.0001
Model 3
 
1.00
0.98 (0.89–1.08)
0.82 (0.74–0.91)
0.89 (0.80–0.99)
0.79 (0.71–0.88)
<0.0001
Infections
       
No. of deaths
922
230
210
165
157
160
 
Model 1
 
1.00
0.87 (0.72–1.05)
0.66 (0.54–0.81)
0.61 (0.50–0.75)
0.60 (0.49–0.74)
<0.0001
Model 2
 
1.00
0.94 (0.78–1.13)
0.75 (0.61–0.91)
0.71 (0.58–0.87)
0.71 (0.58–0.88)
0.0002
Model 3
 
1.00
1.04 (0.85–1.27)
0.84 (0.68–1.05)
0.82 (0.66–1.02)
0.83 (0.67–1.03)
0.023
Other/unknown causes
No. of deaths
5,223
1,215
1,050
1,044
963
951
 
Model 1
 
1.00
0.84 (0.77–0.91)
0.81 (0.74–0.88)
0.72 (0.66–0.78)
0.67 (0.62–0.73)
<0.0001
Model 2
 
1.00
0.88 (0.81–0.96)
0.88 (0.81–0.95)
0.79 (0.73–0.87)
0.76 (0.70–0.83)
<0.0001
Model 3
 
1.00
0.90 (0.83–0.99)
0.91 (0.83–0.99)
0.83 (0.76–0.91)
0.79 (0.72–0.87)
<0.0001
Data are hazard ratios (HR) and 95% confidence interval (CI). The numbers of deaths are for participants who died during follow-up. The co-variables are baseline assessments.
Model 1, Adjusted for age and gender; Model 2, Adjusted for age, gender, the number of cigarettes smoked per day, and time of smoking cessation (<1 years, 1 to 5 years, 5 to 10 years, or ≥10 years before baseline); Model 3, Adjusted for age, gender, the number of cigarettes smoked per day, time of smoking cessation (<1 years, 1 to 5 years, 5 to 10 years, or ≥10 years before baseline), race or ethnicity group, alcohol intake, education level, marital status (yes, no), health status (poor, fair, good, very good), obesity (underweight, overweight, obesity), physical activity, consumption of red meat, total fruit and total vegetables, total energy intake, and hormone usage.

Whole grains and cereal fiber intake with cause-specific mortality

We next tested the associations for cause-specific mortalities. In age- and gender-adjusted and multivariate adjusted models (Models 1, 2 and 3), intakes of whole grains or cereal fiber were inversely associated with risk of death from CVD, cancer, diabetes, respiratory disease, infections, and other/unknown causes (all P trend <0.023). In Model 3, as compared with the lowest quintiles, people in the highest quintile of whole grain intake had 11% (respiratory disease) to 48% (diabetes) lower risk of cause-specific mortality, while people in the highest quintile of cereal fiber intake had 15% (cancer) to 34% (diabetes) lower risk of cause-specific mortality.
When cereal fiber was further adjusted, the associations of whole grains with death from CVD, respiratory disease, infections, and other causes became non-significant; however, the associations with death from cancer and diabetes remained significant (P trend <0.029).

Discussion

In this large prospective cohort study of the US population, we found that high consumption of whole grains or cereal fiber was significantly associated with reduced risk of all-cause mortality and death from CVD, cancer, diabetes, respiratory disease, infections, and other causes. As compared with individuals with the lowest intake of whole grains, those in the highest intake group had a 17% lower risk of all-cause mortality and 11 to 48% lower risk of disease-specific mortality. As compared with individuals with the lowest intake of cereal fiber, those in the highest intake group had a 19% lower risk of all-cause mortality and 15 to 34% lower risk of disease-specific mortality. Furthermore, our results suggested that the protective effects of whole grains may due, at least in the main part, to its cereal fiber component.
To the best of our knowledge, the present study is, thus far, the largest in size regarding deaths in a prospective setting. Our findings are concordant with previously observed protective effects of whole grain intake on CVD, diabetes, and certain cancers [18,19]. Based on a meta-analysis of six cohort studies including 286,125 participants and 10,944 cases, a two servings per day increment in whole grain consumption was associated with a 21% (95% CI, 13–28%) decrease in risk of type 2 diabetes after adjustment for potential confounders and BMI [5]. These findings were confirmed by Ye et al.’s meta-analysis [20], in which it was also reported that compared with never/rare consumers of whole grains, individuals consuming 48 to 80 g of whole grains per day (3 to 5 serving/day) had a 21% lower risk of CVD (relative risk = 0.79; 95% CI, 0.74–0.85). Inverse associations were also reported between intake of whole grains and incident hypertension [21]. In a meta-analysis of 25 prospective studies, the summary relative risk of developing colorectal cancer for 10 g daily of cereal fiber was 0.90 (95% CI, 0.83–0.97), pooled results from six studies showed the relative risk for an increment of three servings daily of whole grains was 0.83 (95% CI, 0.78–0.89) [7]. High whole grain intakes have been related to reduced risk of other cancers, such as digestive cancer, in prospective studies, although the protective effects were not consistently observed [22,23].
Very few previous studies have examined the relationship between whole grains and their components with mortality in humans. Our findings are consistent with the results reported in the Nurses’ Health Study, in which whole grain intake, especially bran, was associated with lower all-cause and CVD mortality in diabetic women [24]. Similarly, higher fiber intake was associated with lower total mortality, particularly mortality from circulatory, digestive, and non-CVD non-cancer inflammatory diseases in a large European prospective study of 452,717 men and women [25]. In a previous analysis among our study samples, it was found that intake of fiber from grains but not from other sources was inversely related to all-cause mortality and death from cancer, CVD, infections, and respiratory disease [9]. In this updated analysis, we found cereal fiber intake was inversely associated with death from diabetes. However, we did not report the associations of specific types of whole grain foods/products with mortality and cause-specific mortality, since it is hard to further differentiate such food groups; this presents a limitation of this observational study.
In addition, we found that the associations of whole grains with death from CVD, respiratory disease, and infections became non-significant after adjustment for cereal fiber intake. The associations with total mortality and death from cancer and diabetes were also largely attenuated, although they remained significant after adjustment for cereal fiber intake. These observations suggest that the protective effects of whole grains on mortality are at least partly mediated by its cereal fiber component. Such a postulation is supported by previous evidence that shows cereal fiber intake is related to an improvement of insulin sensitivity and lipid profile, an increase in protective molecules such as adiponectin, and a reduction in inflammation markers [26-28].
The protective effect of whole grains and fiber consumption on risk of mortality is biologically plausible. Dietary fiber intake is associated with lower levels of inflammation markers, such as C-reactive protein, and tumor necrosis factor α receptor 2, which play key roles in chronic inflammatory conditions [29,30]. Whole grain foods are rich in fiber. Therefore, the anti-inflammatory effects of dietary fiber may help explain, at least in part, the inverse associations of whole grains and fiber consumption with chronic disease death. Moreover, whole grains and cereal fiber have a high content of antioxidants, vitamins, trace minerals, phenolic acids, lignans, and phytoestrogens, which have been associated with a reduced risk of colorectal cancer [31] and lower risk of death from non-cardiovascular, non-cancer inflammatory diseases and respiratory system diseases [32]. In addition, dietary fibers have specific and unique impacts on intestinal microbiota composition and metabolism [33,34]. Additionally, recent studies have related gut microbiota with various chronic diseases such as obesity, CVD, diabetes, and cancer [34,35]. Further functional investigations are warranted to verify these potential mechanisms.

Strengths and limitations of the study

In our study cohort, both whole grains and cereal fiber were correlated with high levels of physical activity and better health status, as well as with low BMI, low levels of smoking, and low intakes of alcohol and red meat. However, our results were less likely due to the potential confounding of these factors because careful adjustment for these factors in our analyses did not significantly change the results. Nevertheless, we acknowledge that the positive associations may still be related to residual confounding of non-measured covariates. Reverse causality might also affect the associations, since people with chronic disease might modify their eating habits by consuming healthy foods including those rich in whole grains and cereal fiber. In our analyses, however, we have excluded patients with cancer, heart disease, and diabetes at baseline and only analyzed the associations with incident cases. Whole grains and cereal fiber intakes were evaluated by self-report at a single time point. It is likely that dietary habits might change during the long (14 years on average) follow-up period, and such temporal patterns were not reflected in our analysis. Moreover, the observational nature of our study limits causality inference between intakes of whole grains or cereal fiber and mortality.

Conclusions

Data from our study indicate that intake of whole grains and cereal fiber may reduce the risk of all-cause mortality and death from chronic diseases such as cancer, CVD, diabetes, respiratory disease, infections, and other causes. Disappearance or attenuation of whole grain associations with total mortality and death from chronic diseases after adjustment for cereal fiber intake suggests that cereal fiber partly accounts for the protective effects of whole grains on mortality.

Acknowledgments

We thank all the participants in the NIH-AARP Diet and Health Study. We also thank Dr. David Hasza for statistical assistance.

Sources of support

This study is funded by an unrestricted research fund from NutraSource. Dr. Qi was supported by grants from the National Heart, Lung, and Blood Institute (HL071981), the National Institute of Diabetes and Digestive and Kidney Diseases (DK091718), the Boston Obesity Nutrition Research Center (DK46200), and United States–Israel Binational Science Foundation Grant 2011036. Dr. Qi was a recipient of the American Heart Association Scientist Development Award (0730094 N). Funding from NutraSource. There were no other relationships or activities that could appear to have influenced the submitted work.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
The Creative Commons Public Domain Dedication waiver (https://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

TH and LQ conceived the study. TH, MX, and LQ analyzed the data and wrote the draft of the paper. MX, AL, SC, and LQ contributed to writing, reviewing, and revising of the paper. LQ is the guarantor. All authors read and approved the final manuscript.
Literatur
2.
Zurück zum Zitat Qi L, Hu FB. Dietary glycemic load, whole grains, and systemic inflammation in diabetes: the epidemiological evidence. Curr Opin Lipidol. 2007;18:3–8.CrossRefPubMed Qi L, Hu FB. Dietary glycemic load, whole grains, and systemic inflammation in diabetes: the epidemiological evidence. Curr Opin Lipidol. 2007;18:3–8.CrossRefPubMed
3.
Zurück zum Zitat Qi L, van Dam RM, Liu S, Franz M, Mantzoros C, Hu FB. Whole-grain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women. Diabetes Care. 2006;29:207–11.CrossRefPubMed Qi L, van Dam RM, Liu S, Franz M, Mantzoros C, Hu FB. Whole-grain, bran, and cereal fiber intakes and markers of systemic inflammation in diabetic women. Diabetes Care. 2006;29:207–11.CrossRefPubMed
4.
Zurück zum Zitat Harland JI, Garton LE. Whole-grain intake as a marker of healthy body weight and adiposity. Public Health Nutr. 2008;11:554–63.CrossRefPubMed Harland JI, Garton LE. Whole-grain intake as a marker of healthy body weight and adiposity. Public Health Nutr. 2008;11:554–63.CrossRefPubMed
5.
Zurück zum Zitat de Munter JS, Hu FB, Spiegelman D, Franz M, van Dam RM. Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review. PLoS Med. 2007;4:e261.CrossRefPubMedPubMedCentral de Munter JS, Hu FB, Spiegelman D, Franz M, van Dam RM. Whole grain, bran, and germ intake and risk of type 2 diabetes: a prospective cohort study and systematic review. PLoS Med. 2007;4:e261.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Mellen PB, Walsh TF, Herrington DM. Whole grain intake and cardiovascular disease: a meta-analysis. Nutr Metab Cardiovasc Dis. 2008;18:283–90.CrossRefPubMed Mellen PB, Walsh TF, Herrington DM. Whole grain intake and cardiovascular disease: a meta-analysis. Nutr Metab Cardiovasc Dis. 2008;18:283–90.CrossRefPubMed
7.
Zurück zum Zitat Aune D, Chan DS, Lau R, Vieira R, Greenwood DC, Kampman E, et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose–response meta-analysis of prospective studies. BMJ. 2011;343:d6617.CrossRefPubMedPubMedCentral Aune D, Chan DS, Lau R, Vieira R, Greenwood DC, Kampman E, et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose–response meta-analysis of prospective studies. BMJ. 2011;343:d6617.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin: Implications fpr metabolic regulation and bioactivity. J Biol Chem. 2003;278:9073–85.CrossRefPubMed Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin: Implications fpr metabolic regulation and bioactivity. J Biol Chem. 2003;278:9073–85.CrossRefPubMed
9.
Zurück zum Zitat Park Y, Subar AF, Hollenbeck A, Schatzkin A. Dietary fiber intake and mortality in the NIH-AARP diet and health study. Arch Intern Med. 2011;171:1061–8.CrossRefPubMedPubMedCentral Park Y, Subar AF, Hollenbeck A, Schatzkin A. Dietary fiber intake and mortality in the NIH-AARP diet and health study. Arch Intern Med. 2011;171:1061–8.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355:763–78.CrossRefPubMed Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006;355:763–78.CrossRefPubMed
11.
Zurück zum Zitat Lacey Jr JV, Brinton LA, Leitzmann MF, Mouw T, Hollenbeck A, Schatzkin A, et al. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort. J Natl Cancer Inst. 2006;98:1397–405.CrossRefPubMed Lacey Jr JV, Brinton LA, Leitzmann MF, Mouw T, Hollenbeck A, Schatzkin A, et al. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort. J Natl Cancer Inst. 2006;98:1397–405.CrossRefPubMed
12.
Zurück zum Zitat Willett W. Nutritional epidemiology: issues and challenges. Int J Epidemiol. 1987;16:312–7.CrossRefPubMed Willett W. Nutritional epidemiology: issues and challenges. Int J Epidemiol. 1987;16:312–7.CrossRefPubMed
13.
Zurück zum Zitat Schatzkin A1, Mouw T, Park Y, Subar AF,Kipnis V, Hollenbeck A, et al. Dietary fiber and whole-grain consumption in relation to colorectal cancer in the NIH-AARP Diet and Health Study. Am J Clin Nutr. 2007;85:1353–60.PubMed Schatzkin A1, Mouw T, Park Y, Subar AF,Kipnis V, Hollenbeck A, et al. Dietary fiber and whole-grain consumption in relation to colorectal cancer in the NIH-AARP Diet and Health Study. Am J Clin Nutr. 2007;85:1353–60.PubMed
14.
Zurück zum Zitat Thompson FE, Kipnis V, Subar AF, Krebs-Smith SM, Kahle LL, Midthune D, et al. Evaluation of 2 brief instruments and a food-frequency questionnaire to estimate daily number of servings of fruit and vegetables. Am J Clin Nutr. 2000;71:1503–10.PubMed Thompson FE, Kipnis V, Subar AF, Krebs-Smith SM, Kahle LL, Midthune D, et al. Evaluation of 2 brief instruments and a food-frequency questionnaire to estimate daily number of servings of fruit and vegetables. Am J Clin Nutr. 2000;71:1503–10.PubMed
17.
Zurück zum Zitat Willett W. Nutritional epidemiology. 2nd ed. New York: Oxford University Press; 1998.CrossRef Willett W. Nutritional epidemiology. 2nd ed. New York: Oxford University Press; 1998.CrossRef
18.
Zurück zum Zitat Borneo R, Leon AE. Whole grain cereals: functional components and health benefits. Food Funct. 2012;3:110–9.CrossRefPubMed Borneo R, Leon AE. Whole grain cereals: functional components and health benefits. Food Funct. 2012;3:110–9.CrossRefPubMed
19.
Zurück zum Zitat Slavin J. Why whole grains are protective: biological mechanisms. Proc Nutr Soc. 2003;62:129–34.CrossRefPubMed Slavin J. Why whole grains are protective: biological mechanisms. Proc Nutr Soc. 2003;62:129–34.CrossRefPubMed
20.
Zurück zum Zitat Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr. 2012;142:1304–13.CrossRefPubMed Ye EQ, Chacko SA, Chou EL, Kugizaki M, Liu S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr. 2012;142:1304–13.CrossRefPubMed
21.
22.
Zurück zum Zitat Egeberg R, Olsen A, Christensen J, Johnsen NF, Loft S, Overvad K, et al. Intake of whole-grain products and risk of prostate cancer among men in the Danish Diet, Cancer and Health cohort study. Cancer Causes Control. 2011;22:1133–9.CrossRefPubMed Egeberg R, Olsen A, Christensen J, Johnsen NF, Loft S, Overvad K, et al. Intake of whole-grain products and risk of prostate cancer among men in the Danish Diet, Cancer and Health cohort study. Cancer Causes Control. 2011;22:1133–9.CrossRefPubMed
23.
Zurück zum Zitat Schatzkin A, Park Y, Leitzmann MF, Hollenbeck AR, Cross AJ. Prospective study of dietary fiber, whole grain foods, and small intestinal cancer. Gastroenterology. 2008;135:1163–7.CrossRefPubMedPubMedCentral Schatzkin A, Park Y, Leitzmann MF, Hollenbeck AR, Cross AJ. Prospective study of dietary fiber, whole grain foods, and small intestinal cancer. Gastroenterology. 2008;135:1163–7.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat He M, van Dam RM, Rimm E, Hu FB, Qi L. Whole-grain, cereal fiber, bran, and germ intake and the risks of all-cause and cardiovascular disease-specific mortality among women with type 2 diabetes mellitus. Circulation. 2010;121:2162–8.CrossRefPubMedPubMedCentral He M, van Dam RM, Rimm E, Hu FB, Qi L. Whole-grain, cereal fiber, bran, and germ intake and the risks of all-cause and cardiovascular disease-specific mortality among women with type 2 diabetes mellitus. Circulation. 2010;121:2162–8.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Chuang SC, Norat T, Murphy N, Olsen A, Tjonneland A, Overvad K, et al. Fiber intake and total and cause-specific mortality in the European Prospective Investigation into Cancer and Nutrition cohort. Am J Clin Nutr. 2012;96:164–74.CrossRefPubMed Chuang SC, Norat T, Murphy N, Olsen A, Tjonneland A, Overvad K, et al. Fiber intake and total and cause-specific mortality in the European Prospective Investigation into Cancer and Nutrition cohort. Am J Clin Nutr. 2012;96:164–74.CrossRefPubMed
26.
Zurück zum Zitat Qi L, Meigs JB, Liu S, Manson JE, Mantzoros C, Hu FB. Dietary fibers and glycemic load, obesity, and plasma adiponectin levels in women with type 2 diabetes. Diabetes Care. 2006;29:1501–5.CrossRefPubMed Qi L, Meigs JB, Liu S, Manson JE, Mantzoros C, Hu FB. Dietary fibers and glycemic load, obesity, and plasma adiponectin levels in women with type 2 diabetes. Diabetes Care. 2006;29:1501–5.CrossRefPubMed
27.
Zurück zum Zitat Esposito K, Giugliano D. Whole-grain intake cools down inflammation. Am J Clin Nutr. 2006;83:1440–1. Author reply 1441–2.PubMed Esposito K, Giugliano D. Whole-grain intake cools down inflammation. Am J Clin Nutr. 2006;83:1440–1. Author reply 1441–2.PubMed
28.
Zurück zum Zitat Weickert MO, Mohlig M, Schofl C, Arafat AM, Otto B, Viehoff H, et al. Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care. 2006;29:775–80.CrossRefPubMed Weickert MO, Mohlig M, Schofl C, Arafat AM, Otto B, Viehoff H, et al. Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care. 2006;29:775–80.CrossRefPubMed
29.
Zurück zum Zitat Ma Y, Griffith JA, Chasan-Taber L, Olendzki BC, Jackson E, Stanek 3rd EJ, et al. Association between dietary fiber and serum C-reactive protein. Am J Clin Nutr. 2006;83:760–6.PubMedPubMedCentral Ma Y, Griffith JA, Chasan-Taber L, Olendzki BC, Jackson E, Stanek 3rd EJ, et al. Association between dietary fiber and serum C-reactive protein. Am J Clin Nutr. 2006;83:760–6.PubMedPubMedCentral
30.
Zurück zum Zitat Wannamethee SG, Whincup PH, Thomas MC, Sattar N. Associations between dietary fiber and inflammation, hepatic function, and risk of type 2 diabetes in older men: potential mechanisms for the benefits of fiber on diabetes risk. Diabetes Care. 2009;32:1823–5.CrossRefPubMedPubMedCentral Wannamethee SG, Whincup PH, Thomas MC, Sattar N. Associations between dietary fiber and inflammation, hepatic function, and risk of type 2 diabetes in older men: potential mechanisms for the benefits of fiber on diabetes risk. Diabetes Care. 2009;32:1823–5.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Slavin JL. Mechanisms for the impact of whole grain foods on cancer risk. J Am Coll Nutr. 2000;19:300S–7.CrossRefPubMed Slavin JL. Mechanisms for the impact of whole grain foods on cancer risk. J Am Coll Nutr. 2000;19:300S–7.CrossRefPubMed
32.
Zurück zum Zitat Jacobs Jr DR, Andersen LF, Blomhoff R. Whole-grain consumption is associated with a reduced risk of noncardiovascular, noncancer death attributed to inflammatory diseases in the Iowa Women’s Health Study. Am J Clin Nutr. 2007;85:1606–14.PubMed Jacobs Jr DR, Andersen LF, Blomhoff R. Whole-grain consumption is associated with a reduced risk of noncardiovascular, noncancer death attributed to inflammatory diseases in the Iowa Women’s Health Study. Am J Clin Nutr. 2007;85:1606–14.PubMed
33.
Zurück zum Zitat Yang J, Martinez I, Walter J, Keshavarzian A, Rose DJ. In vitro characterization of the impact of selected dietary fibers on fecal microbiota composition and short chain fatty acid production. Anaerobe. 2013;23:74–81.CrossRefPubMed Yang J, Martinez I, Walter J, Keshavarzian A, Rose DJ. In vitro characterization of the impact of selected dietary fibers on fecal microbiota composition and short chain fatty acid production. Anaerobe. 2013;23:74–81.CrossRefPubMed
34.
Zurück zum Zitat Parnell JA, Reimer RA. Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR:LA-cp rats. Br J Nutr. 2012;107:601–13.CrossRefPubMed Parnell JA, Reimer RA. Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR:LA-cp rats. Br J Nutr. 2012;107:601–13.CrossRefPubMed
35.
Zurück zum Zitat Saura-Calixto F. Dietary fiber as a carrier of dietary antioxidants: an essential physiological function. J Agric Food Chem. 2011;59:43–9.CrossRefPubMed Saura-Calixto F. Dietary fiber as a carrier of dietary antioxidants: an essential physiological function. J Agric Food Chem. 2011;59:43–9.CrossRefPubMed
Metadaten
Titel
Consumption of whole grains and cereal fiber and total and cause-specific mortality: prospective analysis of 367,442 individuals
verfasst von
Tao Huang
Min Xu
Albert Lee
Susan Cho
Lu Qi
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
BMC Medicine / Ausgabe 1/2015
Elektronische ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-015-0294-7

Weitere Artikel der Ausgabe 1/2015

BMC Medicine 1/2015 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Metformin rückt in den Hintergrund

24.04.2024 DGIM 2024 Kongressbericht

Es hat sich über Jahrzehnte klinisch bewährt. Doch wo harte Endpunkte zählen, ist Metformin als alleinige Erstlinientherapie nicht mehr zeitgemäß.

Myokarditis nach Infekt – Richtig schwierig wird es bei Profisportlern

24.04.2024 DGIM 2024 Kongressbericht

Unerkannte Herzmuskelentzündungen infolge einer Virusinfektion führen immer wieder dazu, dass junge, gesunde Menschen plötzlich beim Sport einen Herzstillstand bekommen. Gerade milde Herzbeteiligungen sind oft schwer zu diagnostizieren – speziell bei Leistungssportlern. 

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.